drugset / Trial / NCT04116632

A Multiple Dose Study to Assess the Safety and Tolerability of BMS-963272 in Obese But Otherwise Healthy Adults

NCT04116632 ↗

Phase 1 Completed 36 enrolled Bristol-Myers Squibb
RandomizedParallel-groupTriple-blindTreatment

Summary

This study will assess the safety and tolerability of multiple doses of BMS-963272 in obese but otherwise healthy participants.

Timeline

Start
2019-09-30
Primary completion
2020-02-10
Completion
2020-02-10

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS-963272 Small molecule — —

Indications

No indication recorded.